Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|January 1, 1981
Phase I clinical trial and pharmacology of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (metoprine) (DDMP) and folinic acid (CF)R de Jager, D Dupont, J J Rodzynek, et al.
Acta Chirurgica Belgica|July 1, 1978
[Should we still operate small cell carcinoma of the lung? (author's transl)]P Van Dale, P Van Houtte, R De Jager, et al.
Seminars in Nuclear Medicine|April 1, 1993
Current status of cancer immunodetection with radiolabeled human monoclonal antibodiesR De Jager, H Abdel-Nabi, A Serafini, et al.
Annals of the New York Academy of Sciences|February 24, 2001
DX-8951f: summary of phase I clinical trialsR De Jager, P Cheverton, K Tamanoi, et al.
Ecological Applications : a Publication of the Ecological Society of America|March 7, 2017
Modelling moose-forest interactions under different predation scenarios at Isle Royale National Park, USANathan R De Jager, Jason J Rohweder, Brian R Miranda, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2023
Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832Rodney Dawson, Andreas H Diacon, Kim Narunsky, et al.
ACS Applied Materials & Interfaces|November 6, 2020
Atomic Precision Graphene Model Compound for Bright Electrochemiluminescence and Organic Light-Emitting DiodesLiuqing Yang, Arthur D Hendsbee, Qin Xue, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1984
Phase II study of 9-hydroxy-2N-methylellipticinium acetateA Clarysse, A Brugarolas, P Siegenthaler, et al.
Cancer Chemotherapy and Pharmacology|October 31, 2003
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecanClaire F Verschraegen, Andrzej P Kudelka, Wei Hu, et al.
Urology|December 1, 1991
Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trialsR De Jager, P Guinan, D Lamm, et al.
Pageof 4